Entrada Therapeutics TRDA
NASDAQ TRDA
$4.66 -0.33 (-6.71%)
As of: Oct 21, 2026 · 3:41 PM EDT

Entrada Therapeutics (TRDA) Operating Expenses (2020 - 2026)

Updated

Entrada Therapeutics (TRDA) posted Operating Expenses of $45.86 million for Q2 2026, down 6.0% from $48.8 million a year earlier but up 6.2% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) Operating Expenses (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Entrada Therapeutics was $181.21 million, up 3.2% year-over-year; for FY2025, it came in at $183.32 million, up 11.9% from FY2024.

  • Annual Operating Expenses has increased for five consecutive years, with a five-year compound annual growth rate of 47.0% (FY2020 to FY2025).
  • In prior years, Entrada Therapeutics' Operating Expenses was $163.77 million in FY2024 (+23.9%), $132.18 million in FY2023 (+35.9%), $97.25 million in FY2022 (+90.2%) and $51.13 million in FY2021 (+91.7%).
  • Quarterly Operating Expenses has run from a low of $14.36 million in Q3 2021 to a high of $48.8 million in Q2 2025 over five years.
  • On a year-over-year basis, Operating Expenses increased in seven of the last eight quarters, with growth averaging 12.5%.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q1 2022, with growth of 163.9%; the weakest was Q2 2026, with a decline of 6.0%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $43.18 million (Q1 2026), $43.51 million (Q4 2025) and $48.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn 10.12 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn 10.56 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn 9.70 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn 18.20 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 6.68 Bn
10 Entrada Therapeutics 196.54 Mn -162.86 Mn - 45.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45.86 Mn
Mar 31, 2026 43.18 Mn
Dec 31, 2025 43.51 Mn
Sep 30, 2025 48.67 Mn
Jun 30, 2025 48.80 Mn
Mar 31, 2025 42.35 Mn
Dec 31, 2024 43.27 Mn
Sep 30, 2024 41.23 Mn
Jun 30, 2024 41.27 Mn
Mar 31, 2024 38.01 Mn
Dec 31, 2023 36.94 Mn
Sep 30, 2023 29.72 Mn
Jun 30, 2023 34.47 Mn
Mar 31, 2023 31.04 Mn
Dec 31, 2022 25.58 Mn
Sep 30, 2022 25.94 Mn
Jun 30, 2022 23.58 Mn
Mar 31, 2022 22.15 Mn
Dec 31, 2021 18.46 Mn
Sep 30, 2021 14.36 Mn
API Access

Entrada Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=TRDA&period=max&api_key=YOUR_API_KEY